Q4 2018 Holdings
Filed 2019-02-13 | 18 holdings | $28.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $15.4M | 245,424 | 54.4% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $6.1M | 1,582,275 | 21.4% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $5.5M | 748,132 | 19.6% |
| Cytokinetics Incorporated(CYTK) | COM NEW | 23282W605 | $1.1M | 175,148 | 3.9% |
| Biohaven Pharmaceutical Holding Company Ltd.(BHVN) | COM | G11196105 | $31.7K | 855,900 | 0.1% |
| Insmed Incorporated(INSM) | COM | 457669307 | $25.9K | 1,977,236 | 0.1% |
| Myokardia, Inc. | COM | 62857M105 | $23.8K | 486,624 | 0.1% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $20.7K | 2,631,258 | 0.1% |
| Immunomedics, Inc.(IMMU) | COM | 452907108 | $17.2K | 1,205,363 | 0.1% |
| Replimune Group, Inc.(REPL) | COM | 76029N106 | $12.3K | 1,229,656 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $10.8K | 400,000 | 0.0% |
| OptiNose, Inc. | COM | 68404V100 | $10.6K | 1,708,545 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $10.5K | 668,361 | 0.0% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $9.5K | 261,823 | 0.0% |
| Eidos Therapeutics, Inc.(EIDXGBP) | COM | 28249H104 | $5.9K | 431,781 | 0.0% |
| Portola Pharmaceuticals, Inc. | COM | 737010108 | $4.9K | 250,000 | 0.0% |
| Si-Bone, Inc.(SIBN) | COM | 825704109 | $4.3K | 205,621 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd. | Class A Common | G5269C101 | $1.8K | 63,922 | 0.0% |